• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Zebra Medical Vision Unveils AI-based Algorithm to Detect Brain Bleeds

by HITC Staff 03/05/2018 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Zebra Medical Vision Enables Radiology Algorithms on Google Cloud With AI1 All-in-One Offering

Zebra Medical Vision, the machine and deep learning company that is creating the next generation services for the healthcare industry. In the past two years Zebra-Med launched different algorithms on a monthly basis to better diagnose breast cancer, heart attacks, and other life-threatening diseases, and now the company is officially releasing the first ever algorithm to detect brain bleeds. This algorithm has just been granted CE approval.

The timely detection of brain bleeds is critical to a patient’s chances of healing. Research has shown that such bleeds are missed anywhere between 12% and 51% of the time, and nearly 6 million people die every year due to brain bleed related conditions. Such wide variability results in significantly reduced quality of patient care.

Zebra-Med’s new algorithm can identify such bleeds and provide a safety net for physicians in acute care settings. This new addition will be included in Zebra-Med’s growing Deep Learning Imaging Analytics platform. The algorithm, capable of detecting Intracranial Hemorrhages – or brain bleeds of different kinds, is now a part of a full suite of automated tools that was announced as Zebra-Meds’ AI1, which offers customers to pay a flat $1 per scan and get an unlimited number of AI algorithms.

The company plans to deploy the algorithm for point of care detection and for worklist prioritization helping physicians identify bleeds more accurately and with minimal delay.  The algorithm broadens Zebra-Med’s AI1 “All-In-One” Imaging Analytics package, which has already analyzed more than 1M scans in over 5 countries.

“We’re excited to announce our first acute care algorithm with the potential to help radiologists better manage their workload, and properly prioritize urgent cases over others,” added Elad Benjamin, Co-Founder and CEO of Zebra Medical Vision in a statement. “This helps take PACS & Worklist management systems to the next level in helping radiologists manage patient care, all in a transparent and globally affordable business model. Over the next few months we plan to release several higher impact algorithms, on our path to provide a versatile AI based automated radiology assistant.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: algorithms, Artificial Intelligence, Artificial Intelligence (AI) Software Platform, Artificial Intelligence Companies, brain bleeds, Cancer Diagnostics, Diagnostic Imaging, Machine Learning, Zebra Medical Vision

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |